About the Szent-Györgyi Prize

The Szent-Györgyi Prize for Progress in Cancer Research is named in memory of Dr. Albert Szent-Györgyi, NFCR’s co-founder and 1937 Nobel Laureate for his study of vitamin C and cell respiration. The prize is a symbol of NFCR’s enduring commitment to uphold Dr. Szent-Györgyi’s vision of curing cancer through innovation and collaboration.

The annual Prize honors scientists whose seminal discovery or pioneering body of work has contributed to cancer prevention, diagnosis, or treatment and has had a lasting impact on understanding cancer, holding the promise of improving or saving lives of cancer patients.

The Szent-Györgyi Prize serves to stimulate continued investment in the pioneering research that will produce scientific breakthroughs and promote public awareness of the importance of basic cancer research and the need to accelerate the translation of these research discoveries into new cancer treatments. In addition to winning the coveted award itself, prize recipients are given a $30,000 honorarium and attend a gala in their honor.

2019 Ceremony

Current Winners

Our 2021 Awardees are a pioneering research duo who paved the path to life-saving t-cell receptor-based cancer immunotherapies.

View Press Release

About the Ceremony

Join us on October 30, 2021 in Washington, DC to honor both our 2020 and 2021 Szent-Gyorgyi Prize Awardees.

Learn More

Steven A. Rosenberg

Past Winners

View all previous awardees of the Szent-Gyorgyi Prize for Progress in Cancer Research.

Explore More